Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 28

1.

Modifiable risk factors of ecstasy use: risk perception, current dependence, perceived control, and depression.

Leung KS, Ben Abdallah A, Copeland J, Cottler LB.

Addict Behav. 2010 Mar;35(3):201-8. doi: 10.1016/j.addbeh.2009.10.003. Epub 2009 Oct 18.

PMID:
19880258
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Adolescent ecstasy and other drug use in the National Survey of Parents and Youth: the role of sensation-seeking, parental monitoring and peer's drug use.

Martins SS, Storr CL, Alexandre PK, Chilcoat HD.

Addict Behav. 2008 Jul;33(7):919-33. doi: 10.1016/j.addbeh.2008.02.010. Epub 2008 Feb 21.

PMID:
18355973
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Depressive symptomatology in young adults with a history of MDMA use: a longitudinal analysis.

Falck RS, Wang J, Carlson RG.

J Psychopharmacol. 2008 Jan;22(1):47-54. doi: 10.1177/0269881107078293.

PMID:
18187532
[PubMed - indexed for MEDLINE]
4.

Increases in alcohol and marijuana use during the transition out of high school into emerging adulthood: The effects of leaving home, going to college, and high school protective factors.

White HR, McMorris BJ, Catalano RF, Fleming CB, Haggerty KP, Abbott RD.

J Stud Alcohol. 2006 Nov;67(6):810-22.

PMID:
17060997
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Users' perceptions of the risks and effects of taking ecstasy (MDMA): a questionnaire study.

Murphy PN, Wareing M, Fisk J.

J Psychopharmacol. 2006 May;20(3):447-55.

PMID:
16574719
[PubMed - indexed for MEDLINE]
6.

Prediction of adolescent smoking from family and social risk factors at 5 years, and maternal smoking in pregnancy and at 5 and 14 years.

O'Callaghan FV, O'Callaghan M, Najman JM, Williams GM, Bor W, Alati R.

Addiction. 2006 Feb;101(2):282-90.

PMID:
16445557
[PubMed - indexed for MEDLINE]
7.

From "Candy Kids" to "Chemi-Kids": a typology of young adults who attend raves in the midwestern United States.

McCaughan JA, Carlson RG, Falck RS, Siegal HA.

Subst Use Misuse. 2005;40(9-10):1503-23.

PMID:
16048830
[PubMed - indexed for MEDLINE]
8.

Conceptions of risk in the lives of club drug-using youth.

Kelly BC.

Subst Use Misuse. 2005;40(9-10):1443-59.

PMID:
16048827
[PubMed - indexed for MEDLINE]
9.

Drug use practices among MDMA/ecstasy users in Ohio: a latent class analysis.

Carlson RG, Wang J, Falck RS, Siegal HA.

Drug Alcohol Depend. 2005 Aug 1;79(2):167-79. Epub 2005 Feb 24.

PMID:
16002026
[PubMed - indexed for MEDLINE]
10.

Respondent-driven sampling to recruit MDMA users: a methodological assessment.

Wang J, Carlson RG, Falck RS, Siegal HA, Rahman A, Li L.

Drug Alcohol Depend. 2005 May 9;78(2):147-57. Epub 2004 Dec 22.

PMID:
15845318
[PubMed - indexed for MEDLINE]
11.

Is ecstasy perceived to be safe? A critical survey.

Gamma A, Jerome L, Liechti ME, Sumnall HR.

Drug Alcohol Depend. 2005 Feb 14;77(2):185-93.

PMID:
15664720
[PubMed - indexed for MEDLINE]
12.

MDMA/Ecstasy use among young people in Ohio: perceived risk and barriers to intervention.

Carlson RG, Falck RS, McCaughan JA, Siegal HA.

J Psychoactive Drugs. 2004 Jun;36(2):181-9.

PMID:
15369199
[PubMed - indexed for MEDLINE]
13.

Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP.

Tancer M, Johanson CE.

Drug Alcohol Depend. 2003 Oct 24;72(1):33-44.

PMID:
14563541
[PubMed - indexed for MEDLINE]
14.

Acute, sub-acute and long-term subjective consequences of 'ecstasy' (MDMA) consumption in 430 regular users.

Verheyden SL, Henry JA, Curran HV.

Hum Psychopharmacol. 2003 Oct;18(7):507-17.

PMID:
14533132
[PubMed - indexed for MEDLINE]
15.

It's a rave new world: estimating the prevalence and perceived harm of ecstasy and other drug use among club rave attendees.

Yacoubian GS Jr, Boyle C, Harding CA, Loftus EA.

J Drug Educ. 2003;33(2):187-96.

PMID:
12929709
[PubMed - indexed for MEDLINE]
16.

MDMA misrepresentation: an unresolved problem for Ecstasy users.

Hayner GN.

J Psychoactive Drugs. 2002 Apr-Jun;34(2):195-8. Review.

PMID:
12691209
[PubMed - indexed for MEDLINE]
17.

Preventing problems in Ecstasy users: reduce use to reduce harm.

Baggott MJ.

J Psychoactive Drugs. 2002 Apr-Jun;34(2):145-62. Review.

PMID:
12691205
[PubMed - indexed for MEDLINE]
18.

Altered states: the clinical effects of Ecstasy.

Cole JC, Sumnall HR.

Pharmacol Ther. 2003 Apr;98(1):35-58. Review.

PMID:
12667887
[PubMed - indexed for MEDLINE]
19.

The content of ecstasy tablets: implications for the study of their long-term effects.

Cole JC, Bailey M, Sumnall HR, Wagstaff GF, King LA.

Addiction. 2002 Dec;97(12):1531-6.

PMID:
12472637
[PubMed - indexed for MEDLINE]
20.

Ecstasy abuse and dependence among adolescents and young adults: applicability and reliability of DSM-IV criteria.

Cottler LB, Womack SB, Compton WM, Ben-Abdallah A.

Hum Psychopharmacol. 2001 Dec;16(8):599-606.

PMID:
12404539
[PubMed - as supplied by publisher]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk